Luts & Greenleigh Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Sell |
13,917
-89
| -0.6% | -$16.5K | 2.48% | 6 |
|
|
2025
Q1 | $2.93M | Buy |
14,006
+222
| +2% | +$46.5K | 2.92% | 5 |
|
|
2024
Q4 | $2.45M | Buy |
13,784
+27
| +0.2% | +$4.8K | 2.42% | 6 |
|
|
2024
Q3 | $2.72M | Buy |
13,757
+131
| +1% | +$25.9K | 2.61% | 5 |
|
|
2024
Q2 | $2.34M | Buy |
+13,626
| New | +$2.34M | 2.43% | 6 |
|
|
2023
Q4 | $2.1M | Sell |
13,554
-7
| -0.1% | -$1.09K | 2.65% | 5 |
|
|
2023
Q3 | $2.02M | Sell |
13,561
-53
| -0.4% | -$7.9K | 2.51% | 5 |
|
|
2023
Q2 | $1.83M | Sell |
13,614
-88
| -0.6% | -$11.9K | 2.26% | 5 |
|
|
2023
Q1 | $2.18M | Sell |
13,702
-261
| -2% | -$41.6K | 2.77% | 6 |
|
|
2022
Q4 | $2.26M | Buy |
+13,963
| New | +$2.26M | 2.86% | 4 |
|